Results 311 to 320 of about 5,576,726 (364)

Disproportionality analysis of adverse events in advanced lung cancer treated with atezolizumab plus platinum-based combination chemotherapy. [PDF]

J Pharm Health Care Sci
Hazama K, Imai T, Tochikura N, Washinosu S, Ootsuka S, Hanada K.   +5 more
europepmc   +1 more source

Machine learning-based risk prediction of outcomes in patients hospitalized with COVID-19 in Australia: the AUS-COVID Score. [PDF]

J Am Med Inform Assoc
Sritharan HP, Nguyen H, van Gaal W, Kritharides L, Chow CK, Bhindi R, AUS-COVID Investigators .   +6 more
europepmc   +1 more source

Safety and adverse events associated with dexmedetomidine for sedation in adult ICU patients: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Ding Y, Wang X, Li X, He J, Teng X, Chen G.   +5 more
europepmc   +1 more source

Optimal Ex Post Risk Adjustment in Markets with Adverse Selection *

, 2019
Anastasios Dosis
openalex   +1 more source

Perspective of using <i>in vitro</i> models to understand immunotherapy-induced cytokine release syndrome. [PDF]

Front Immunol
Perkins E, Cooper C, Lund E, Alb M, Morgan H, Fogal B, Hewitt P, Mazein A, Ostaszewski M, Sewald K.   +9 more
europepmc   +1 more source

Nomogram-based prediction of continued axial elongation in children undergoing orthokeratology. [PDF]

Front Med (Lausanne)
Fu X, Yi Q, Mao X, Zhen S, Han F, Zhu Q, Du Z, Pan X, Hu Y, Ying J, Li X, Wu Y.   +11 more
europepmc   +1 more source

Adverse Selection in Acquisitions of Small Manufacturing Firms: A Comparison of Private and Public Targets

, 2005
Jung‐Chin Shen, Jeffrey J. Reuer
openalex   +1 more source

Optimal Insurance with Adverse Selection [PDF]

Edward Schlee, Hector Chade
core